CLINICAL_TRIALS
trial_result
· 2017-10-10
Clinical Trial Update: Determining the Sustained Virologic Response of Declatasvir in Egyptian Patients With Hepatitis C Virus Genotype 4
Summary
A clinical trial update investigating the sustained virologic response of daclatasvir in Egyptian patients with hepatitis C virus genotype 4.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zagazig University | Conditions: Hepatitis C | Status: UNKNOWN